Stock Events

Stock Events

Apellis Pharmaceuticals (APLS) Q4 2024 Earnings

5NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.73

-0.59

-0.44

-0.29

Details

Expected EPS

-0.294942

Actual EPS

-0.46

Surprise EPS

-0.17

Surprise Percent

+55.96%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.46 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.